Carl C Hanson
Pharmacy at Daley Cir, Parker, CO
License number
Colorado 9708
Issued Date
Mar 9, 1972
Renew Date
Sep 1, 2016
Expiration Date
Oct 31, 2017
Type
Pharmacist
Address
Address
4825 Daley Cir, Parker, CO 80134
Professional information
Chelated 8-Hydroxyquinoline For The Treatment Of Epithelial Lesions
US Patent:
6476014, Nov 5, 2002
Filed:
Jan 2, 2001
Appl. No.:
09/601304
Inventors:
Russel T. Jordan - Fort Collins CO
Carl C. Hanson - Parker CO
Frank S. Potestio - Parker CO
Carl C. Hanson - Parker CO
Frank S. Potestio - Parker CO
Assignee:
Dermex Pharmaceuticals, LLC - Fort Collins CO
International Classification:
A61K 31555
US Classification:
514187, 514312
Abstract:
Oxinates including 8-hydroxyquinoline and a heavy metal are topically applied to epidermal lesions for therapeutic effect, wherein said epithelial lesions selected from the croup consisting of cancerous lesions, precancerous lesions, cysts and warts; and permitting said composition to destroy said lesion.
Chelated 8-Hydroxyquinoline And Use Thereof In A Method Of Treating Epithelial Lesions
US Patent:
6774124, Aug 10, 2004
Filed:
Sep 18, 2002
Appl. No.:
10/247526
Inventors:
Russel T. Jordan - Fort Collins CO
Carl C. Hanson - Parker CO
Frank S. Potestio - Parker CO
Carl C. Hanson - Parker CO
Frank S. Potestio - Parker CO
Assignee:
Dermex Pharmaceuticals, LLC - Fort Collins CO
International Classification:
A61K 31555
US Classification:
514187, 514312
Abstract:
A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier is effective in treating the bite of the brown recluse spider.
Chelated 8-Hydroxyquinoline And Use Thereof In A Method Of Treating Epithelial Lesions
US Patent:
7846919, Dec 7, 2010
Filed:
Feb 10, 1998
Appl. No.:
09/021421
Inventors:
Russel T. Jordan - Fort Collins CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Assignee:
Dermex Pharmaceuticals, LLC - Parker CO
International Classification:
A61K 31/555, A61K 31/47, A61K 31/32
US Classification:
514187, 514312, 424641
Abstract:
Oxinates including 8-hydroxyquinoline and a heavy metal are topically applied to epidermal lesions for therapeutic effect. The zinc oxinate compositions are shown to be therapeutically effective against The therapeutic composition demonstrates selective toxicity with a therapeutic index of one-hundred percent on human lung cancer, breast cancer, melanoma, venereal warts, male veruoca warts, lesions produced by human papilloma virus, basal cell carcinoma, solar keratosis, and Kaposi's sarcoma. In veterinary applications where dogs, cats, and horses are the patients, the composition shows a one-hundred percent therapeutic index with selective toxicity against eye cancer, sarcoids, sarcoma, malignant melanoma, rectal adenoma, histiocytoma, and sebaceous adenoma.
Chelated 8-Hydroxyquinoline And Use Thereof In A Method Of Treating Epithelial Lesions
US Patent:
7060696, Jun 13, 2006
Filed:
Sep 18, 2002
Appl. No.:
10/247161
Inventors:
Russel T. Jordan - Fort Collins CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Assignee:
Dermex Pharmaceuticals, LLC - Parker CO
International Classification:
A61K 31/555, A61K 31/47, A61K 33/32
US Classification:
514187, 514312, 424641
Abstract:
A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier demonstrates therapeutic efficacy in treating lesions including cancerous lesions, precancerous lesions, cysts and warts.
Chelated 8-Hydroxyquinoline And Use Thereof In A Method Of Treating Epithelial Lesions
US Patent:
8012954, Sep 6, 2011
Filed:
May 16, 2006
Appl. No.:
11/434613
Inventors:
Russel T. Jordan - Fort Collins CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Carl C. Hanson - Parker CO, US
Frank S. Potestio - Parker CO, US
Assignee:
Dermex Pharmaceuticals, LLC - Parker CO
International Classification:
A61K 31/555, A61K 31/47, A61K 31/32
US Classification:
514187, 514312, 424 49, 424641
Abstract:
A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier demonstrates therapeutic efficacy in treating lesions including cancerous lesions, precancerous lesions, cysts and warts.